SIGILON THERAPEUTICS INC (SGTX)
Institutional ownership reported to the SEC as of Q3 2023, across 12 quarters.
1
Reporting holders
$4.5K
Reported value
0.0%
Held as options
-16
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| IFP Advisors, Inc | $4.5K | 200 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2023 | 1 | $4.5K | 200 | 1 | 0 | 0 | 0.0% |
| Q2 2023 | 17 | $26.9M | 1,181,625 | 17 | 0 | 0 | 1.1% |
| Q1 2023 | 30 | $17.1M | 18,351,685 | 7 | 5 | 4 | 0.2% |
| Q4 2022 | 24 | $5.9M | 16,935,683 | 2 | 1 | 6 | 0.2% |
| Q3 2022 | 29 | $8.5M | 16,936,003 | 1 | 5 | 11 | 0.1% |
| Q2 2022 | 32 | $14.2M | 17,075,784 | 5 | 3 | 13 | 0.0% |
| Q1 2022 | 46 | $26.8M | 18,233,664 | 4 | 8 | 20 | 0.2% |
| Q4 2021 | 48 | $52.6M | 18,950,467 | 12 | 16 | 9 | 0.5% |
| Q3 2021 | 45 | $109.3M | 19,291,531 | 9 | 19 | 8 | 0.2% |
| Q2 2021 | 52 | $210.5M | 19,621,370 | 11 | 17 | 16 | 0.0% |
| Q1 2021 | 51 | $438.5M | 19,621,935 | 20 | 9 | 11 | 0.0% |
| Q4 2020 | 45 | $941.9M | 19,635,552 | 45 | 0 | 0 | 0.0% |